Susan Benton
CIK: 0001373649
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IRD
Opus Genetics, Inc.
Director
Discretionary Trading P&L
Holdings
About Benton Susan
Benton Susan (SEC CIK 0001373649) files insider reports with the SEC as Director of Opus Genetics, Inc. (IRD).
Signal8 holds 2 ownership filings by Benton Susan, all Form 4s, filed between May 2, 2025 and Apr 22, 2026. Those filings report 2 transactions, from Apr 30, 2025 to Apr 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Benton Susan's filings is in DURHAM, NC.
Recent filings by Benton Susan
Other insiders filing for Opus Genetics, Inc. (IRD)
- SCHACHLE JOSEPH K, Chief Operating Officer
- YERXA BENJAMIN R, President
- Gagnon Robert E., Chief Financial Officer
- Magrath George, Chief Executive Officer
- Foundation Fighting Blindness Retinal Degeneration Fund, Director
- Gallagher Cam, Director